Search

Your search keyword '"Brice, Alexis"' showing total 2,709 results

Search Constraints

Start Over You searched for: Author "Brice, Alexis" Remove constraint Author: "Brice, Alexis"
2,709 results on '"Brice, Alexis"'

Search Results

1. Investigation of the genetic aetiology of Lewy body diseases with and without dementia

2. SARA captures disparate progression and responsiveness in spinocerebellar ataxias

3. Identification of a DAGLB Mutation in a Non-Chinese Patient with Parkinson's Disease

4. Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy

5. Correction: Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy

6. The parkin V380L variant is a genetic modifier of Machado–Joseph disease with impact on mitophagy

7. Genome-wide determinants of mortality and motor progression in Parkinson’s disease

8. Genotype–phenotype correlation in PRKN-associated Parkinson’s disease

10. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

12. Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data

13. Motor neuron pathology in CANVAS due to RFC1 expansions

14. Isolated parkinsonism is an atypical presentation of GRN and C9orf72 gene mutations

15. Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups.

16. RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses

17. CAG repeat mosaicism is gene specific in spinocerebellar ataxias

18. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

19. Clinical and genetic keys to cerebellar ataxia due to FGF14 GAA expansions

20. TMEM240 mutations cause spinocerebellar ataxia 21 with mental retardation and severe cognitive impairment

21. Homozygous GRN mutations: unexpected phenotypes and new insights into pathological and molecular mechanisms

22. Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease

23. Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes

24. Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

25. Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study

26. Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort

28. Extreme phenotypic heterogeneity in non-expansion spinocerebellar ataxias

29. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

30. Plasma lysosphingolipids in GRN-related diseases: Monitoring lysosomal dysfunction to track disease progression

31. Nonsteroidal Anti-inflammatory Use and LRRK2 Parkinson's Disease Penetrance.

32. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study.

33. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

34. Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood

35. Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study

36. Intermediate repeat expansions of TBP and STUB1: Genetic modifier or pure digenic inheritance in spinocerebellar ataxias?

37. The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease

38. Structural brain splitting is a hallmark of Granulin-related frontotemporal dementia

39. Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson’s disease patients

41. Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort

42. Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trial

43. Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases.

44. Mutations in DCC cause isolated agenesis of the corpus callosum with incomplete penetrance

45. Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson’s disease

46. Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia

47. Increasing involvement of CAPN1 variants in spastic ataxias and phenotype-genotype correlations

48. Factors Influencing Health-Related Quality of Life of Patients with Spinocerebellar Ataxia.

49. Health-Related Quality of Life in Patients with Spinocerebellar Ataxia: a Validation Study of the EQ-5D-3L.

50. SCAview: an Intuitive Visual Approach to the Integrative Analysis of Clinical Data in Spinocerebellar Ataxias.

Catalog

Books, media, physical & digital resources